FDA Inspection 620136 — Merck And Company
The FDA completed an inspection of Merck And Company on Oct 8, 2009 in Springfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 8, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Springfield, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)